Product image of Meropenem Aurobindo (Meropenem Trihydrate) supplied by GNH India

Meropenem Aurobindo

Active Ingredient:
Meropenem Trihydrate
Origin:
EU

Meropenem Aurobindo (Meropenem Trihydrate)

Meropenem, the active ingredient in Meropenem Aurobindo, is a carbapenem antibiotic presented as an intravenous formulation for hospital use. It treats a range of serious bacterial infections in adult and paediatric patients when other antibiotics are ineffective.

GNH India supplies Meropenem Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Aurobindo Pharma România S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem used for severe bacterial infections that require intravenous therapy.

  • Complicated intra‑abdominal infections: provides rapid bactericidal activity to resolve deep abdominal sepsis.
  • Complicated urinary tract infections: eradicates resistant uropathogens causing pyelonephritis.
  • Nosocomial pneumonia: treats hospital‑acquired lung infections, including ventilator‑associated pneumonia.
  • Meningitis: penetrates the cerebrospinal fluid to eliminate causative bacteria.
  • Severe sepsis and septic shock: offers critical coverage against multidrug‑resistant organisms.

How It Works

  • Meropenem binds to penicillin‑binding proteins (PBPs) on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis, resulting in a bactericidal effect against a wide range of Gram‑positive and Gram‑negative organisms.

Side Effects

Adverse reactions may occur with any intravenous antibiotic. Monitoring and prompt reporting are essential.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhoea: may be watery and self‑limiting.
  • Rash: erythematous skin eruption.
  • Infusion site reactions: redness or pain at the injection site.

Serious or Rare Side Effects

  • Seizures: especially in patients with pre‑existing CNS disorders.
  • Clostridioides difficile colitis: severe diarrhoea due to gut flora disruption.
  • Anaphylaxis: acute, potentially life‑threatening hypersensitivity.
  • Severe neutropenia: marked reduction in white blood cells.
  • Renal toxicity: impaired kidney function in susceptible individuals.
  • Stevens‑Johnson syndrome: rare mucocutaneous blistering disorder.

Precautions & Warnings

Careful patient assessment and monitoring are required before and during therapy.

  • Renal function monitoring: adjust dose in renal impairment.
  • Hypersensitivity assessment: discontinue if allergic reaction occurs.
  • CNS disorder caution: avoid in patients with seizure history.
  • Concomitant valproic acid: increased seizure risk, consider alternatives.
  • Drug‑induced neutropenia: monitor complete blood count regularly.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Potential drug‑drug interactions should be evaluated to minimise adverse outcomes.

Major Interactions (Avoid)

  • Valproic acid: heightened risk of seizures.
  • CNS depressants: additive sedative effects.
  • Loop diuretics: may exacerbate nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Aminoglycosides: monitor renal function for additive toxicity.
  • Vancomycin: watch for combined nephrotoxic potential.
  • Warfarin: observe INR for possible anticoagulation changes.

Frequently Asked Questions

Meropenem Aurobindo is indicated for serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, bacterial meningitis, and severe sepsis or septic shock when a broad‑spectrum carbapenem is required.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, weakening the wall and causing bacterial lysis, which results in a rapid bactericidal effect against many Gram‑positive and Gram‑negative organisms.

The dosage of Meropenem Aurobindo is determined by the prescribing clinician based on the infection type, severity, patient weight, renal function, and local antimicrobial guidelines. Only a qualified healthcare professional should set the dosing regimen.

Safety data for meropenem in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where needed) and required import documentation.

Meropenem shares the carbapenem class’s broad‑spectrum activity and resistance to most β‑lactamases, but it has a slightly lower affinity for certain Pseudomonas strains compared with imipenem. Its dosing flexibility and lower risk of seizures make it a preferred option in many severe infections.

Meropenem Aurobindo should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze the product, and avoid prolonged exposure to temperatures above the recommended range to maintain stability.

The product is supplied for intravenous infusion. It is reconstituted with the appropriate diluent, then administered over a prescribed period, usually 15‑30 minutes, under aseptic conditions by qualified healthcare personnel.

Serious adverse events include seizures, especially in patients with pre‑existing CNS disorders, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Prompt medical attention is required if these occur.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any component of the formulation should avoid the drug. Caution is also advised for individuals with a history of seizures, severe renal impairment, or those receiving valproic acid, unless the prescriber determines the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem Trihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT